Professor Anton Hagenbeek 1948–2021: Father of MRD and lymphoma expert

• by Bob Löwenberg, Marie José Kersten, Robert Peter Gale, Marinus van Oers

• July 19, 2021

CORSA study finds spike-specific blunted immune responses in lymphoma patients after SARS-CoV-2 vaccine

• by Lucia Mazzotti, Gerardo Musuraca, Fabio Affaticati, Esther Bartholomeus, Diana Campillo-Davo, Carole Faghel, Chiara Zingaretti, Flavia Foca, Claudio Cerchione, Valentina Ancarani, Patricia Borges de Souza, Fabio Nicolini, Anna De Lucia, Anna Gaimari, Oriana Nanni, Vittorio Sambri, Giovanni Martinelli, Francesco Malaspina, Pieter Meysman, Eva Lion, Massimiliano Mazza

• May 20, 2026

Epstein-Barr virus associated diseases: Immune alterations and targeted approaches

• by Shijia Cao, Jie Xiong, Jiayi Zhao, Wei-Li Zhao

• May 8, 2026

The First NCI-Designated Comprehensive Cancer Center Using 3D Genomics Testing to Diagnose Lymphoma and Sarcoma—a True Game Changer

Diagnosing lymphoma and sarcoma can be extraordinarily complex, with more than 70 recognized subtypes of lymphoma and more than 100 distinct types of sarcoma. Many subtypes share similar features yet behave in dramatically different ways in standard testing, leaving oncologists with diagnostic quandaries and delays to treatment.

• by

• February 24, 2026

• 4 min